Related topics: immune system , t cells
Journal of Experimental Medicine
hideThe Journal of Experimental Medicine is a peer-reviewed academic journal that publishes research papers and commentaries in the biomedical area. Topics covered include immunology, inflammation, infectious disease, hematopoiesis, cancer, stem cells and vascular biology. The journal has a history of predominantly publishing basic research, although studies in human subjects form an increasing proportion of papers published (around 10% in 2004).
JEM was founded in 1896, which makes it among the longest established of scientific journals. Initially published at the Johns Hopkins University, it was taken over in 1905 by the Rockefeller University Press, the current publishers, and is published on a not-for-profit basis. There is no single Editor-in-Chief, with eleven academic Editors and a hundred strong Advisory Board.
JEM is published monthly. An online archive of articles back to 1896 is available in text and PDF formats (material from 1996 and earlier is only available in PDF). Material over 6 months old is freely accessible, and access to all papers is also provided free of charge to developing countries. All of the content of JEM is also deposited in PubMed Central where it is available to the public 6 months after publication. Copyright to articles remains with the authors and third parties may re-use JEM content under the terms of a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license described at http://creativecommons.org/licenses/by-nc-sa/3.0/.
For more information about Journal of Experimental Medicine, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with journal of experimental medicine
Septic shock: Nitric oxide beneficial after all
Dec 15, 2009 |
5 / 5 (1) |
0
Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units. By inducing the release of nitric oxide (NO) gas ...
Hindering HIV-1-fighting immune cells
Medicine & Health / HIV & AIDS
Dec 14, 2009 |
not rated yet |
0
Immune proteins called HLA molecules help to activate killer T cell responses against pathogens. But according to a study that will be published online on December 14th in the Journal of Experimental Medicine, one partic ...
Microbes help mothers protect kids from allergies
Dec 07, 2009 |
not rated yet |
1
A pregnant woman's exposure to microbes may protect her child from developing allergies later in life. Researchers in Marburg, Germany find that exposure to environmental bacteria triggers a mild inflammatory response in ...
Defects in T cells make West Nile virus more deadly in older adults
Dec 04, 2009 |
not rated yet |
0
(PhysOrg.com) -- West Nile virus is more deadly in older adults due to defects in T cells, according to a study conducted by researchers from the UA College of Medicine.
Researchers discover antibody receptor identity, propose renaming immune-system gene
Nov 20, 2009 |
5 / 5 (2) |
0
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on ...
Sperm may play leading role in spreading HIV
Medicine & Health / HIV & AIDS
Oct 26, 2009 |
5 / 5 (1) |
0
Sperm, and not just the fluid it bathes in, can transmit HIV to macrophages, T cells, and dendritic cells (DCs), report a team led by Ana Ceballos at the University of Buenos Aires in Argentina. By infecting ...
'Natural killer' cells keep immune system in balance
Oct 01, 2009 |
4 / 5 (1) |
0
Natural killer, or NK cells, are part of our innate immune system. A healthy body produces them to respond early during infection. They are activated and they kill cells infected with a given virus.
Study identifies two chemicals that could lead to new drugs for genetic disorders
Sep 28, 2009 |
5 / 5 (1) |
0
UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could ...
Immune defect is key to skin aging
Aug 28, 2009 |
4 / 5 (2) |
0
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered why older people may be so vulnerable to cancer and infections in the skin. The team from UCL has shown in human volunteers ...
How meningitis bacteria attack the brain
Aug 18, 2009 |
not rated yet |
0
(PhysOrg.com) -- A specific protein on the surface of a common bacterial pathogen allows the bacteria to leave the bloodstream and enter the brain, initiating the deadly infection known as meningitis. The new finding, which ...
Teasing apart T helper cells
Jul 27, 2009 |
not rated yet |
0
The cytokine IL-9 promotes a multiple sclerosis-like disease in mice, according to a new study by Nowak et al. published online on July 13th in the Journal of Experimental Medicine. In a related Commentary, Richar ...
Toward an explanation for Crohn's disease?
Jul 09, 2009 |
not rated yet |
0
Twenty-five per cent of Crohn's disease patients have a mutation in what is called the NOD2 gene, but it is not precisely known how this mutation influences the disease. The latest study by Dr. Marcel Behr, of the Research ...
Immune genes adapt to parasites
May 25, 2009 |
5 / 5 (3) |
0
Thank parasites for making some of our immune proteins into the inflammatory defenders they are today, according to a population genetics study that will appear in the June 8 issue of the Journal of Experimental Medicine (onlin ...
A longer lasting tumor blocker
Apr 28, 2009 |
not rated yet |
0
On the heels of dismaying reports that a promising antitumor drug could, in theory, shorten patients' long-term survival, comes a promising study by a Japanese team of researchers that suggests a potentially better option. ...
Researchers find molecular 'key' to successful blood stem cell transplants
Apr 22, 2009 |
not rated yet |
0
University of British Columbia researchers have discovered a "molecular key" that could help increase the success of blood stem cell transplants, a procedure currently used to treat diseases such as leukemia, Hodgkin's lymphoma ...
